Tela Bio Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $8.77
- Today's High:
- $8.965
- Open Price:
- $8.84
- 52W Low:
- $6.4
- 52W High:
- $13.18
- Prev. Close:
- $8.92
- Volume:
- 64438
Company Statistics
- Market Cap.:
- $233.61 million
- Book Value:
- 1.634
- Revenue TTM:
- $49.18 million
- Operating Margin TTM:
- -82.43%
- Gross Profit TTM:
- $27.85 million
- Profit Margin:
- -88.46%
- Return on Assets TTM:
- -34.78%
- Return on Equity TTM:
- -226.24%
Company Profile
Tela Bio Inc had its IPO on 2019-11-08 under the ticker symbol TELA.
The company operates in the Healthcare sector and Medical Devices industry. Tela Bio Inc has a staff strength of 173 employees.
Stock update
Shares of Tela Bio Inc opened at $8.84 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $8.77 - $8.97, and closed at $8.9.
This is a -0.22% slip from the previous day's closing price.
A total volume of 64,438 shares were traded at the close of the day’s session.
In the last one week, shares of Tela Bio Inc have slipped by -6.71%.
Tela Bio Inc's Key Ratios
Tela Bio Inc has a market cap of $233.61 million, indicating a price to book ratio of 8.798 and a price to sales ratio of 5.3206.
In the last 12-months Tela Bio Inc’s revenue was $49.18 million with a gross profit of $27.85 million and an EBITDA of $-39701000. The EBITDA ratio measures Tela Bio Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Tela Bio Inc’s operating margin was -82.43% while its return on assets stood at -34.78% with a return of equity of -226.24%.
In Q2, Tela Bio Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 39.3%.
Tela Bio Inc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-2.15 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Tela Bio Inc’s profitability.
Tela Bio Inc stock is trading at a EV to sales ratio of 5.0008 and a EV to EBITDA ratio of -5.0205. Its price to sales ratio in the trailing 12-months stood at 5.3206.
Tela Bio Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $94.39 million
- Total Liabilities
- $13.05 million
- Operating Cash Flow
- $-157000.00
- Capital Expenditure
- $157000
- Dividend Payout Ratio
- 0%
Tela Bio Inc ended 2024 with $94.39 million in total assets and $0 in total liabilities. Its intangible assets were valued at $94.39 million while shareholder equity stood at $40.01 million.
Tela Bio Inc ended 2024 with $0 in deferred long-term liabilities, $13.05 million in other current liabilities, 24000.00 in common stock, $-297042000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $65.27 million and cash and short-term investments were $65.27 million. The company’s total short-term debt was $343,000 while long-term debt stood at $40.21 million.
Tela Bio Inc’s total current assets stands at $89.17 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $7.89 million compared to accounts payable of $2.25 million and inventory worth $14.10 million.
In 2024, Tela Bio Inc's operating cash flow was $-157000.00 while its capital expenditure stood at $157000.
Comparatively, Tela Bio Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $8.9
- 52-Week High
- $13.18
- 52-Week Low
- $6.4
- Analyst Target Price
- $17.6
Tela Bio Inc stock is currently trading at $8.9 per share. It touched a 52-week high of $13.18 and a 52-week low of $13.18. Analysts tracking the stock have a 12-month average target price of $17.6.
Its 50-day moving average was $9.55 and 200-day moving average was $10.26 The short ratio stood at 6.06 indicating a short percent outstanding of 0%.
Around 123.2% of the company’s stock are held by insiders while 6705.1% are held by institutions.
Frequently Asked Questions About Tela Bio Inc
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.